OKLAHOMA CITY & TORRANCE, Calif.–(BUSINESS WIRE)–This new collaboration provides a scalable, integrated solution for developing and manufacturing complex peptide drugs efficiently.

VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union after receiving a CE Mark late last year. enVista Aspire combines novel Intermediate Optimized optics, which are designed for a broader depth of focus*, with the proven benefits of the enVista® platfor

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)—- $MD–Pediatrix Announces Strategic Initiatives For
Enhanced Shareholder Value Creation

BOSTON & NEW HAVEN, Conn.–(BUSINESS WIRE)–Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The financing was co-led by Samsara BioCapital and Enavate Sciences, alongside other new investors Regeneron Ventures, Pfizer Ventures and YK Bioventures, as well as existing investors Canaan Partners, Sanofi Ventures, Taiho Ventures, Osage Venture Partners, HongShan Capital Group, and Connecticut Innovation

SAN DIEGO–(BUSINESS WIRE)—- $REVB #GEMINI–Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, wants to remind all shareholders to vote their proxies for the January 17, 2025 special meeting of stockholders. In particular, a vote for Proposal 2, the redomicile of the Company from Delaware to Nevada will save the Company at least $200,000.00 per year in franc

SAN DIEGO–(BUSINESS WIRE)– #biobam–BioBam, a leading bioinformatics solutions provider, proudly presents OmicsBox Version 3.4 at the San Diego Plant and Animal Genome Conference (PAG 32). This latest release introduces a range of enhancements designed to address the evolving needs of modern genomics and transcriptomics research. A key highlight of OmicsBox 3.4 is the integration of CellKB, a robust cell-type prediction tool for single-cell RNA sequencing (scRNA-Seq) analysis. CellKB streamlines scRNA-

HANGZHOU, China–(BUSINESS WIRE)–Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex Diseases